ArticleiScience2024
HIV-1 interaction with an
Abstract read
In one paragraph
Article in iScience, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Trial
- Hijacking the Host: Post-Translational Modifications as Molecular Switches in HIV Persistence and Immune Evasion.Journal of medical virology · 2026Review
- HIV-1 interactions with sialic acid-binding bacterial lectins promote virus infectivity in vitro and mucosal transmission in humanized mice.bioRxiv : the preprint server for biology · 2026Article
- Comprehensive analysis of gp120 glycosylation to explore differences between transmitter/founder and chronic HIV-1 isolates.Glycobiology · 2026Article
- Galectin-8 binds HIV envelope glycoproteins with high affinity and promotes viral infectivity.Frontiers in cellular and infection microbiology · 2026Article
- HIV-1 interactions with sialic acid-binding bacterial lectins promote virus infectivityFrontiers in cellular and infection microbiology · 2026Article
- Bridging Viral Glycobiology and Lectin Biotechnology for Antiviral and Diagnostic Strategies.ACS bio & med chem Au · 2025Review
- Article
Corrections and comments
- Update of
Authors and funding
19 authors.
Daniel W HeindelDivison of Infectious Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Dania M Figueroa AcostaDivison of Infectious Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Marisa GoffDivison of Infectious Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Clauvis Kunkeng YengoDivison of Infectious Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Muzafar JanDivison of Infectious Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Xiaomei LiuDivison of Infectious Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Xiao-Hong WangVA New York Harbor Healthcare System-Manhattan, New York, NY, USA.
Mariya I PetrovaDepartment of Bioscience Engineering, University of Antwerp, Antwerp, Belgium.
Mo ZhangDepartment of Medicine, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA.
Manish SagarDepartment of Medicine, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA.
Phillip BarnetteDivision of Pathobiology and Immunology, Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, OR, USA.
Shilpi PandeyDivision of Pathobiology and Immunology, Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, OR, USA.
Ann J HessellDivision of Pathobiology and Immunology, Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, OR, USA.
Kun-Wei ChanDepartment of Biochemistry and Molecular Pharmacology New York University Grossman School of Medicine, New York, NY, USA.
Xiang-Peng KongDepartment of Biochemistry and Molecular Pharmacology New York University Grossman School of Medicine, New York, NY, USA.
Benjamin K ChenDivison of Infectious Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Lara K MahalDepartment of Chemistry, University of Alberta, Edmonton, AB, Canada.
Barbara A BensingDepartment of Medicine, San Francisco Veterans Affairs Medical Center and University of California, San Francisco, CA, USA.
Catarina E HioeDivison of Infectious Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Funding
TRAINING PROGRAM: MECHANISMS OF VIRUS-HOST INTERACTIONST32AI007647 · NIAID · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI Domenico Tortorella · 2000 to 2026
$11.5MStructure and immunogenicity of novel trimeric HIV-1 Env immunogensR01AI145655 · NIAID · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI KONG, XIANGPENG · 2019 to 2023
$4.7MUsing immune complex vaccines to optimize antibody responses to HIV EnvR01AI148327 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI HIOE, CATARINA E · 2020 to 2025
$4.5MHarnessing Abs specific for immunogenic and conserved Env epitopes to protect against HIVR01AI139290 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI HIOE, CATARINA E · 2018 to 2022
$4.1MAntibody dependent cellular cytotoxicity and HIV-1 mother to child transmissionR01AI172843 · NIAID · BOSTON MEDICAL CENTER · PI SAGAR, MANISH · 2022 to 2025
$3.5MHIV immune evasion and escape through T cell virological synapsesR37AI148064 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI BENJAMIN K CHEN · 2022 to 2026
$3.1MHIV-1 mucosal transmission and persistenceK24AI145661 · NIAID · BOSTON MEDICAL CENTER · PI SAGAR, MANISH · 2019 to 2023
$908kHIV immune evasion and escape through T cell virological synapsesR56AI148064 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI CHEN, BENJAMIN K · 2020 to 2020
$538kBiologic consequences of HIV-1 interaction with bacteriaR21AI150909 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI HIOE, CATARINA E · 2020 to 2021
$501kUsing streptococcal sialoglycan binding proteins to characterize MUC7 glycoformsR03DE029516 · NIDCR · NORTHERN CALIFORNIA INSTITUTE/RES/EDU · PI BENSING, BARBARA ANNE · 2020 to 2021
$307kEffect of an Fc Gamma Receptor Polymorphism on Antibody-Dependent Enhancement of Zika Virus InfectionF31AI154695 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI GOFF, MARISA · 2021 to 2023
$136kBLR&D Research Career Scientist Award ApplicationIK6BX004607 · VA · JAMES J PETERS VA MEDICAL CENTER · PI HIOE, CATARINA E · 2019 to 2025
–BLRD VA I01 BX003860BLRD VA IK6 BX004607NIAID NIH HHS F31 AI154695NIAID NIH HHS K24 AI145661NIAID NIH HHS R01 AI139290NIAID NIH HHS R01 AI145655NIAID NIH HHS R01 AI148327NIAID NIH HHS R01 AI172843NIAID NIH HHS R21 AI150909NIAID NIH HHS R37 AI148064NIAID NIH HHS R56 AI148064NIAID NIH HHS T32 AI007647NIDCR NIH HHS R03 DE029516
Abstract
Bacteria dysbiosis and its accompanying inflammation or compromised mucosal integrity is associated with an increased risk of HIV-1 transmission. However, HIV-1 may also bind bacteria or bacterial products to impact infectivity and transmissibility. This study evaluated HIV-1 interactions with bacteria through glycan-binding lectins. The
Indexed as
ImmunologyVirology
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.